id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-N-0002-0032,FDA,FDA-2023-N-0002,"New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications, Change of Sponsor, Change of Sponsor Address",Rule,Final Rule,2024-02-27T05:00:00Z,2024,2,2024-02-27T05:00:00Z,,2024-02-27T14:10:51Z,2024-03765,0,0,0900006486432bd9
FDA-2023-N-0002-0031,FDA,FDA-2023-N-0002,"New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal
of Approval of New Animal Drug Applications; Change of Sponsor;
Change of Sponsor Address",Rule,Final Rule,2023-12-06T05:00:00Z,2023,12,2023-12-06T05:00:00Z,,2024-05-06T12:04:48Z,2023-26545,0,0,09000064862ff365
FDA-2023-N-0002-0029,FDA,FDA-2023-N-0002,"FOI Summary sN 038-439, approved April 10, 2023",Supporting & Related Material,Background Material,2023-08-16T04:00:00Z,2023,8,,,2023-08-16T17:21:47Z,,0,0,0900006485e365b3
FDA-2023-N-0002-0026,FDA,FDA-2023-N-0002,"FOI Summary oN 141-562, approved May 5, 2023",Supporting & Related Material,Background Material,2023-08-16T04:00:00Z,2023,8,,,2023-08-16T17:21:45Z,,0,0,0900006485e365b0
FDA-2023-N-0002-0028,FDA,FDA-2023-N-0002,"FOI Summary oN 141-571, approved May 1, 2023",Supporting & Related Material,Background Material,2023-08-16T04:00:00Z,2023,8,,,2023-08-16T17:21:46Z,,0,0,0900006485e365b2
FDA-2023-N-0002-0023,FDA,FDA-2023-N-0002,"FOI Summary oA 200-750, approved May 25, 2023",Supporting & Related Material,Background Material,2023-08-16T04:00:00Z,2023,8,,,2023-08-16T17:21:43Z,,0,0,0900006485e365ad
FDA-2023-N-0002-0020,FDA,FDA-2023-N-0002,"New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Applications, Change of Sponsor, Change of Sponsor Address",Rule,Final Rule,2023-08-16T04:00:00Z,2023,8,2023-08-16T04:00:00Z,,2023-08-16T13:52:41Z,2023-17454,0,0,0900006485e5693b
FDA-2023-N-0002-0025,FDA,FDA-2023-N-0002,"FOI Summary oN 141-555, approved June 9, 2023",Supporting & Related Material,Background Material,2023-08-16T04:00:00Z,2023,8,,,2023-08-16T17:21:44Z,,0,0,0900006485e365af
FDA-2023-N-0002-0030,FDA,FDA-2023-N-0002,"FOI Summary sN 141-406, Approved June 21, 2023",Supporting & Related Material,Background Material,2023-08-16T04:00:00Z,2023,8,,,2023-08-16T17:21:48Z,,0,0,0900006485e365b4
FDA-2023-N-0002-0021,FDA,FDA-2023-N-0002,"FOI Summary oA 200-612, approved April 5, 2023",Supporting & Related Material,Background Material,2023-08-16T04:00:00Z,2023,8,,,2023-08-16T17:21:41Z,,0,0,0900006485e365ab
FDA-2023-N-0002-0022,FDA,FDA-2023-N-0002,"FOI Summary oA 200-748, approved May 10, 2023",Supporting & Related Material,Background Material,2023-08-16T04:00:00Z,2023,8,,,2023-08-16T17:21:42Z,,0,0,0900006485e365ac
FDA-2023-N-0002-0024,FDA,FDA-2023-N-0002,"FOI Summary oA 200-751, approved June 22, 2023",Supporting & Related Material,Background Material,2023-08-16T04:00:00Z,2023,8,,,2023-08-16T17:21:43Z,,0,0,0900006485e365ae
FDA-2023-N-0002-0027,FDA,FDA-2023-N-0002,"FOI Summary oN 141-570, appproved April 20, 2023",Supporting & Related Material,Background Material,2023-08-16T04:00:00Z,2023,8,,,2023-08-16T17:21:45Z,,0,0,0900006485e365b1
FDA-2023-N-0002-0008,FDA,FDA-2023-N-0002,"FOI Summary oA 200-737 - Approved February 2, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T20:07:03Z,,0,0,09000064859c26c6
FDA-2023-N-0002-0018,FDA,FDA-2023-N-0002,"FOI Summary sA 200-721 - Approved January 12, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T20:10:20Z,,0,0,09000064859c26cd
FDA-2023-N-0002-0007,FDA,FDA-2023-N-0002,"FOI Summary oA 200-736 - Approved January 13, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T20:06:49Z,,0,0,09000064859c26c5
FDA-2023-N-0002-0017,FDA,FDA-2023-N-0002,"FOI Summary sA 200-701 - Approved February 9, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T20:09:48Z,,0,0,09000064859c26cc
FDA-2023-N-0002-0019,FDA,FDA-2023-N-0002,"FOI Summary sN 141-426 - Approved January 12, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T20:10:47Z,,0,0,09000064859c28ad
FDA-2023-N-0002-0015,FDA,FDA-2023-N-0002,"FOI Summary oA 200-746 - Approved March 30, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T20:09:16Z,,0,0,09000064859c27f9
FDA-2023-N-0002-0003,FDA,FDA-2023-N-0002,"FOI Summary oA 200-732 - Approved January 5, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T19:54:47Z,,0,0,09000064859c2628
FDA-2023-N-0002-0016,FDA,FDA-2023-N-0002,"FOI Summary oA 200-747 - Approved March 31, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T20:09:29Z,,0,0,09000064859c26cb
FDA-2023-N-0002-0013,FDA,FDA-2023-N-0002,"FOI Summary oA 200-744 - Approved March 29, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T20:08:48Z,,0,0,09000064859c26ca
FDA-2023-N-0002-0011,FDA,FDA-2023-N-0002,"FOI Summary oA 200-741 - Approved February 24, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T20:08:18Z,,0,0,09000064859c26c9
FDA-2023-N-0002-0006,FDA,FDA-2023-N-0002,"FOI Summary oA 200-735 - Approved January 13, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T20:06:28Z,,0,0,09000064859c26c4
FDA-2023-N-0002-0012,FDA,FDA-2023-N-0002,"FOI Summary oA 200-743 - Approved March 21, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T20:08:32Z,,0,0,09000064859c26a5
FDA-2023-N-0002-0005,FDA,FDA-2023-N-0002,"FOI Summary oA 200-734 - Approved January 12, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T19:56:13Z,,0,0,09000064859c265d
FDA-2023-N-0002-0004,FDA,FDA-2023-N-0002,"FOI Summary oA 200-733 - Approved January 12, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T19:55:04Z,,0,0,09000064859c269f
FDA-2023-N-0002-0014,FDA,FDA-2023-N-0002,"FOI Summary oA 200-745 - Approved March 21, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T20:09:02Z,,0,0,09000064859c27f8
FDA-2023-N-0002-0009,FDA,FDA-2023-N-0002,"FOI Summary oA 200-738 - Approved January 11, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T20:07:23Z,,0,0,09000064859c26c7
FDA-2023-N-0002-0010,FDA,FDA-2023-N-0002,"FOI Summary oA 200-739 - Approved February 2, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T20:08:04Z,,0,0,09000064859c26c8
FDA-2023-N-0002-0002,FDA,FDA-2023-N-0002,"FOI Summary oA 200-611 - Approved January 11, 2023",Supporting & Related Material,Background Material,2023-05-03T04:00:00Z,2023,5,,,2023-05-04T19:54:16Z,,0,0,09000064859c2658
FDA-2023-N-0002-0001,FDA,FDA-2023-N-0002,"New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal
of Approval of New Animal Drug Applications",Rule,Final Rule,2023-05-03T04:00:00Z,2023,5,2023-05-03T04:00:00Z,,2023-05-03T20:15:01Z,2023-09212,0,0,09000064859c163d